Literature DB >> 18475518

Effect of PAF on polyrnorphonuclear leucocyte plasma membrane polarity: a fluorescence study.

A Kantar1, P L Giorgi, R Fiorini.   

Abstract

The effect of PAF on the plasma membrane polarity of polymorphonuclear leukocytes (PMNs) was investigated by measuring the steady-state fluorescence emission spectra of 2-dimethylamino(6-1auroyl) naphthalene (Laurdan), which is known to be incorporated at the hydrophobic-hydrophilic interface of the bilayer, displaying spectral sensitivity to the polarity of its surrounding. Laurdan shows a marked steady-state emission blue-shift in non-polar solvents, with respect to polar solvents. Our results demonstrate that PAF (10(-7) M) induces a blue shift of the fluorescence emission spectra of Laurdan. These changes are blocked in the presence of the PAF antagonist, L-659,989. Our data indicate that the interaction between PAF and PMNs is accompanied by a decrease in polarity in the hydrophobic-hydrophilic interface of the plasma membrane.

Entities:  

Year:  1993        PMID: 18475518      PMCID: PMC2365388          DOI: 10.1155/S0962935193000225

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  22 in total

1.  Complement activation and lung permeability during cardiopulmonary bypass.

Authors:  S D Tennenberg; C W Clardy; W W Bailey; J S Solomkin
Journal:  Ann Thorac Surg       Date:  1990-10       Impact factor: 4.330

2.  Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo.

Authors:  U H von Andrian; J D Chambers; L M McEvoy; R F Bargatze; K E Arfors; E C Butcher
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

3.  N-(fluorenyl-9-methoxycarbonyl) amino acids, a class of antiinflammatory agents with a different mechanism of action.

Authors:  R M Burch; M Weitzberg; N Blok; R Muhlhauser; D Martin; S G Farmer; J M Bator; J R Connor; M Green; C Ko
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

4.  NPC 15669 enhances survival and reverses leukopenia in endotoxin-treated mice.

Authors:  L Noronha-Blob; V C Lowe; M Weitzberg; R M Burch
Journal:  Eur J Pharmacol       Date:  1991-07-09       Impact factor: 4.432

5.  Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear.

Authors:  N B Vedder; R K Winn; C L Rice; E Y Chi; K E Arfors; J M Harlan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

6.  Assessment of leukocyte involvement during ischemia and reperfusion of intestine.

Authors:  M B Grisham; J N Benoit; D N Granger
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

7.  Perioperative alteration of neutrophil functions after open heart and other major surgeries. A comparative study.

Authors:  J Utoh; T Yamamoto; T Kambara; H Goto; Y Miyauchi
Journal:  J Cardiovasc Surg (Torino)       Date:  1989 Jul-Aug       Impact factor: 1.888

8.  Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans.

Authors:  M E Faymonville; J Pincemail; J Duchateau; J M Paulus; A Adam; G Deby-Dupont; C Deby; A Albert; R Larbuisson; R Limet
Journal:  J Thorac Cardiovasc Surg       Date:  1991-08       Impact factor: 5.209

9.  Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass.

Authors:  K Bando; R Pillai; D E Cameron; J D Brawn; J A Winkelstein; G M Hutchins; B A Reitz; W A Baumgartner
Journal:  J Thorac Cardiovasc Surg       Date:  1990-05       Impact factor: 5.209

10.  Monoclonal antibodies against porcine LFA-1: species cross-reactivity and functional effects of beta-subunit-specific antibodies.

Authors:  J E Hildreth; V Holt; J T August; M D Pescovitz
Journal:  Mol Immunol       Date:  1989-09       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.